NYSE

Dole plc Ordinary Shares (DOLE)

β™₯ 735 Thanks from members

Dole plc (DOLE) displays a resilient financial profile in 2026, bolstered by strong revenue growth, favorable health and wellness tailwinds including GLP-1 adoption, and strategic asset divestitures and acquisitions, despite facing anticipated fresh fruit cost pressures.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore β†’